0114 232 9292 connect@medilink.co.uk

Monthly Archives: May 2016

Scalp cooling offers patients a safe and effective treatment for preventing chemotherapy-induced hair loss

Chicago, Illinois – June 6, 2016 - Scalp cooling is a safe, feasible and an effective treatment in the prevention of chemotherapy induced alopecia (CIA) according to a German study being presented at the American Society of Clinical Oncology Annual meeting (ASCO). Dr Christian Kurbacher, Gynecologic Oncologist for Gynecologic Center Bonn-Friedensplatz.will present the results of…
Read more

Read The Benefits Of The National Institute for Health Research Today In Latest Report

RAND Europe, a not-for-profit research institute whose mission is to help improve policy and decision-making through research and analysis, has published a research report highlighting the positive changes resulting from NIHR’s support of research. The National Institute for Health Research (NIHR) funds and supports world-leading clinical and applied health and social care research, as well…
Read more

Medilink Corporate Partner Nabarro Releases Latest Report

Medilink Corporate Partner Nabarro has released their latest report 'Taking AIM: ambition and fear in the UK tech sector'.  For US technology companies with “unicorn” ambitions, listing on Nasdaq is seen as a natural step – a means to raise new capital for growth and to realise the investment of early investors. In the UK, the…
Read more

Medilink member Tissuemed announces TissuePatch™ approval in China

Leeds-based Medilink member Tissuemed Ltd has been granted regulatory approval of its TissuePatch™ range of ultra-thin surgical sealant films by the Chinese FDA (‘CFDA’). TissuePatch™ is the first and only synthetic sealant to be approved by the CFDA, giving Tissuemed sole access to a significant medical device market that is being driven by both an…
Read more